"TruCare is Located in Du Bois, PA. Dr. Stainbrook and her staff provides quality care and preventive medicine. We offer treatment and diagnosis for Internal Medicine and Infectious Diseases."

During the past decade, TruCare Internal Medicine and Infectious Diseases conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "TruCare Internal Medicine and Infectious Diseases" #1 sponsor was "Finch Research and Development LLC." with 1 trials, followed by "Kaleido Biosciences" with 1 trials sponsored, "Melinta Therapeutics, Inc." with 1 trials sponsored, "TruCare Internal Medicine & Infectious Disease" with 1 trials sponsored and "Vedanta Biosciences, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "TruCare Internal Medicine and Infectious Diseases" #1 collaborator was "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "TruCare Internal Medicine and Infectious Diseases" are "CDI" (1 trials), "Clostridium Difficile" (1 trials), "Clostridium Difficile Infection" (1 trials), "Clostridium Difficile Infection Recurrence" (1 trials) and "Gram-Positive Bacterial Infections" (1 trials). Many other conditions were trialed in "TruCare Internal Medicine and Infectious Diseases" in a lesser frequency.

Most popular intervention types in "TruCare Internal Medicine and Infectious Diseases" are "Drug" (2 trials), "Other" (2 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "CP101" (1 trials), "KB109 + Self Supportive Care (SSC)" (1 trials), "OraQuick HCV Rapid Antibody Test" (1 trials) and "Oritavancin" (1 trials). Other intervention names were less common.

The vast majority of trials in "TruCare Internal Medicine and Infectious Diseases" are 5 trials for "All" genders.

Currently, there are NaN active trials in "TruCare Internal Medicine and Infectious Diseases". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in TruCare Internal Medicine and Infectious Diseases, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in TruCare Internal Medicine and Infectious Diseases, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".